Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% above its 5-year average of -0.36, around the middle of its 5-year range (-4.19–3.52).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -0.40.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
-0.40
DEBT TO EQUITY RATIO AVG 3Y
-0.60
DEBT TO EQUITY RATIO AVG 5Y
-0.36
DEBT TO EQUITY RATIO AVG 10Y
0.04
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13
median of 587 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Kyntra Bio, Inc.
Market Cap
$24.29M
Debt to Equity Ratio
0.00
TTM Avg
-0.40
3Y Avg
-0.60
5Y Avg
-0.36
Market Cap
$24.70M
Debt to Equity Ratio
0.17
TTM Avg
1.46
3Y Avg
1.37
5Y Avg
1.15
Market Cap
$24.74M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$22.43M
Debt to Equity Ratio
0.51
TTM Avg
0.86
3Y Avg
0.77
5Y Avg
0.62
Market Cap
$21.07M
Debt to Equity Ratio
0.03
TTM Avg
0.04
3Y Avg
0.12
5Y Avg
0.10
Market Cap
$27.80M
Debt to Equity Ratio
1.64
TTM Avg
4.27
3Y Avg
7.87
5Y Avg
4.84
Market Cap
$27.96M
Debt to Equity Ratio
0.01
TTM Avg
0.03
3Y Avg
0.24
5Y Avg
0.25
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.29M | 0.00 | -0.40 | -0.60 | -0.36 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | 0.17 | 1.46 | 1.37 | 1.15 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.74M | 0.00 | 0.00 | 0.00 | 0.00 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | 0.51 | 0.86 | 0.77 | 0.62 |
| LeonaBio, Inc. (LONA)vs › | $21.69M | 0.02 | 0.03 | 0.02 | 0.01 |
| InspireMD, Inc. (NSPR)vs › | $26.91M | 0.06 | 0.06 | 0.06 | 0.07 |
| Modular Medical, Inc. (MODD)vs › | $21.07M | 0.03 | 0.04 | 0.12 | 0.10 |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.80M | 1.64 | 4.27 | 7.87 | 4.84 |
| iTonic Holdings Ltd. (ITOC)vs › | $27.96M | 0.01 | 0.03 | 0.24 | 0.25 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | N/A | 0.00 | 0.02 | 0.01 |
Debt/Equity
0.00
Current Ratio
2.69
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | -0.44 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | -1.24 |
| 2025-06-30 | -0.33 |
| 2025-03-31 | -0.34 |
| 2024-12-31 | -0.32 |
| 2024-09-30 | -0.33 |
| 2024-06-30 | -0.63 |
| 2024-03-31 | -0.81 |
| 2023-12-31 | -0.83 |
| 2023-09-30 | -0.98 |
| 2023-06-30 | -1.53 |
| 2023-03-31 | -1.78 |
| 2022-12-31 | -4.19 |
| 2022-09-30 | 3.52 |
| 2022-06-30 | 0.91 |
| 2022-03-31 | 0.61 |
| 2021-12-31 | 0.48 |
| 2021-09-30 | 0.31 |
| 2021-06-30 | 0.40 |
| 2021-03-31 | 0.10 |
| 2020-12-31 | 0.09 |
| 2020-09-30 | 0.09 |
| 2020-06-30 | 0.11 |
| 2020-03-31 | 0.10 |
| 2019-12-31 | 0.10 |
| 2019-09-30 | 0.09 |
| 2019-06-30 | 0.09 |
| 2019-03-31 | 0.12 |
| 2018-12-31 | 0.19 |
| 2018-09-30 | 0.21 |
| 2018-06-30 | 0.20 |
| 2018-03-31 | 0.20 |
| 2017-12-31 | 0.17 |
| 2017-09-30 | 0.17 |
| 2017-06-30 | 0.42 |
| 2017-03-31 | 0.74 |
| 2016-12-31 | 0.62 |
| 2016-09-30 | 0.55 |
| 2016-06-30 | 0.50 |
| 2016-03-31 | 0.62 |
| 2015-12-31 | 0.55 |
| 2015-09-30 | 0.45 |
| 2015-06-30 | 0.38 |
| 2015-03-31 | 0.52 |
| 2014-12-31 | 0.44 |
| 2014-09-30 | 1.19 |
| 2014-06-30 | 0.87 |
| 2014-03-31 | 1.80 |
| 2013-12-31 | 1.21 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
